These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2941262)

  • 1. The pharmacology of orally administered ciprofloxacin.
    Brittain DC; Scully BE; McElrath MJ; Steinman R; Labthavikul P; Neu HC
    Drugs Exp Clin Res; 1985; 11(5):339-41. PubMed ID: 2941262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin.
    Brittain DC; Scully BE; McElrath MJ; Steinman R; Labthavikul P; Neu HC
    J Clin Pharmacol; 1985 Mar; 25(2):82-8. PubMed ID: 3157705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form.
    Schuck EL; Dalhoff A; Stass H; Derendorf H
    Infection; 2005 Dec; 33 Suppl 2():22-8. PubMed ID: 16518708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin concentrations in human fluids and tissues following a single oral dose.
    Esposito S; Galante D; Barba D; D'Errico G; Mazzone A; Montanaro S
    Int J Clin Pharmacol Res; 1987; 7(3):181-6. PubMed ID: 3596861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
    Gonzalez MA; Uribe F; Moisen SD; Fuster AP; Selen A; Welling PG; Painter B
    Antimicrob Agents Chemother; 1984 Nov; 26(5):741-4. PubMed ID: 6517556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ciprofloxacine: evaluation of its biliary elimination in man].
    Brogard JM; Jehl F; Arnaud JP; Lévy P; Peladan F; Blicklé JF; Monteil H
    Schweiz Med Wochenschr; 1985 Mar; 115(13):448-53. PubMed ID: 3158073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose].
    Guibert J; Kitzis MD; Acar JF
    Pathol Biol (Paris); 1994 Jun; 42(6):587-92. PubMed ID: 7854859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the pharmacology of intravenously administered ciprofloxacin.
    Drusano GL
    Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.
    Siefert HM; Maruhn D; Scholl H
    Arzneimittelforschung; 1986 Oct; 36(10):1503-10. PubMed ID: 3101707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis.
    Goldfarb J; Wormser GP; Inchiosa MA; Guideri G; Diaz M; Gandhi R; Goltzman C; Mascia AV
    J Clin Pharmacol; 1986 Mar; 26(3):222-6. PubMed ID: 2937812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.
    Tartaglione TA; Raffalovich AC; Poynor WJ; Espinel-Ingroff A; Kerkering TM
    Antimicrob Agents Chemother; 1986 Jan; 29(1):62-6. PubMed ID: 2942101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.
    Britten CD; Baker SD; Denis LJ; Johnson T; Drengler R; Siu LL; Duchin K; Kuhn J; Rowinsky EK
    Clin Cancer Res; 2000 Sep; 6(9):3459-68. PubMed ID: 10999729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and food interaction of MK-462 in healthy males.
    Cheng H; Polvino WJ; Sciberras D; Yogendran L; Cerchio KA; Christie K; Olah TV; McLoughlin D; James I; Rogers JD
    Biopharm Drug Dispos; 1996 Jan; 17(1):17-24. PubMed ID: 8991488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Stein D; Breitenbucher R; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):279-84. PubMed ID: 3410603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.